← All Sponsors
SPONSOR

Vertex Pharmaceuticals Incorporated

Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 1, Phase 2
Conditions studied: Proteinuric Kidney DiseaseCystic Fibrosis
NCT06794996 Phase 2
Recruiting

Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

Proteinuric Kidney Disease
United States View Trial →
NCT05668741 Phase 1, Phase 2
Recruiting

A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)

Cystic Fibrosis
United States, Australia, Belgium View Trial →